DE60141681D1 - Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen - Google Patents

Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen

Info

Publication number
DE60141681D1
DE60141681D1 DE60141681T DE60141681T DE60141681D1 DE 60141681 D1 DE60141681 D1 DE 60141681D1 DE 60141681 T DE60141681 T DE 60141681T DE 60141681 T DE60141681 T DE 60141681T DE 60141681 D1 DE60141681 D1 DE 60141681D1
Authority
DE
Germany
Prior art keywords
administration
composition
vaccine
compositions
immunogenic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60141681T
Other languages
English (en)
Inventor
Albert Kapikian
Robert Chanock
Stephen Udem
Timo Vesikari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE60141681D1 publication Critical patent/DE60141681D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60141681T 2000-01-28 2001-01-26 Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen Expired - Lifetime DE60141681D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17868900P 2000-01-28 2000-01-28
PCT/US2001/002686 WO2001054718A2 (en) 2000-01-28 2001-01-26 Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions

Publications (1)

Publication Number Publication Date
DE60141681D1 true DE60141681D1 (de) 2010-05-12

Family

ID=22653531

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60141681T Expired - Lifetime DE60141681D1 (de) 2000-01-28 2001-01-26 Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen

Country Status (7)

Country Link
US (1) US7431931B2 (de)
EP (1) EP1251869B1 (de)
AT (1) ATE462446T1 (de)
AU (1) AU784344B2 (de)
CA (1) CA2398428C (de)
DE (1) DE60141681D1 (de)
WO (1) WO2001054718A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0503337D0 (en) * 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
WO2007009081A2 (en) * 2005-07-07 2007-01-18 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services A hexavalent bovine rotavirus reassortant composition designed for use in developing countries
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571385A (en) 1983-06-27 1986-02-18 The United States Of America As Represented By The Department Of Health And Human Services Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors

Also Published As

Publication number Publication date
EP1251869A2 (de) 2002-10-30
CA2398428C (en) 2015-09-08
AU784344B2 (en) 2006-03-16
WO2001054718A2 (en) 2001-08-02
ATE462446T1 (de) 2010-04-15
AU3304001A (en) 2001-08-07
CA2398428A1 (en) 2001-08-02
US20040223981A1 (en) 2004-11-11
WO2001054718A3 (en) 2002-04-18
EP1251869B1 (de) 2010-03-31
US7431931B2 (en) 2008-10-07

Similar Documents

Publication Publication Date Title
JP2012506411A5 (de)
EA200701519A1 (ru) Живая аттенуированная ротавирусная вакцина для перорального введения
ES2257769T3 (es) Metodo para la preparacion de vacunas multivalentes.
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
NO20015073D0 (no) Vaksiner
RU2011120706A (ru) Композиции вакцин, содержащие мутированный белок, связывающий фактор н
SI2473605T1 (en) CEPIVO PCSK9
ATE512670T1 (de) Meningokokken-konjugat-impfung
CY1110140T1 (el) Εμβολιασμος με μηνιγγοκοκκικο συζευγμα
CY1107452T1 (el) Διαδερμικη μορφη χορηγησης για τη θεραπεια του συνδρομου ανησυχων ποδιων
HUP0401606A2 (hu) West Nile vakcina
RU2013119946A (ru) Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
DE60331412D1 (de) Hiv-vakzine und anwendungsverfahren
WO2005074460A3 (en) Methods of enhancing immune response in the intradermal compartment and compounds useful in the methods
ATE416788T1 (de) Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme
DE60141681D1 (de) Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen
AR048671A1 (es) Procedimiento de vacunacion contra la infeccion testicular por bvdv
CA2354045A1 (en) New cancer treatments
BRPI9912485B8 (pt) composição imunogênica multivalente
WO2004006851A3 (en) Mycoplasma gallisepticum formulation
EA200301125A1 (ru) Вакцины, включающие в качестве адъюванта интерферон типа i, и связанные с этим способы
MD3121F1 (en) Method of viral hepatitis B prophylaxis
MY137709A (en) Method for obtaining antigenic structures of high cross reactivity and their use in formulations
ES2280948T3 (es) Composiciones de vacunas basadas en gangliosidos para administracion por via subcutanea.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition